前收市價 | 10.39 |
開市 | 10.61 |
買盤 | 9.73 x 800 |
賣出價 | 12.01 x 800 |
今日波幅 | 10.33 - 10.73 |
52 週波幅 | 9.74 - 30.22 |
成交量 | |
平均成交量 | 757,696 |
市值 | 532.435M |
Beta 值 (5 年,每月) | 1.13 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.07 |
業績公佈日 | 2024年8月08日 |
遠期股息及收益率 | 0.24 (2.31%) |
除息日 | 2024年5月31日 |
1 年預測目標價 | 12.83 |
In today’s volatile market, identifying stocks to sell is critical to preserving capital invested. As economic uncertainties loom, learning which investments might falter can safeguard portfolios. Here, the focus is on three stocks that hold vulnerabilities, signaling potential downturns. Each company faces unique adversities. To begin with, the first one contends with fluctuating international currencies impacting the top-line. Meanwhile, the second one needs help with subdued consumer spending
Nu Skin (NUS) has been dealing with challenges related to customer and affiliate acquisition. However, product launches, technological advancements and strength in the Rhyz business bode well.
Finding overvalued stocks to sell is crucial for investors to safeguard their portfolios in today’s erratic markets. Here, the emphasis is on three well-known businesses whose valuation measures have lately come under investigation. Though each firm works in a different industry—cash, direct marketing, or cryptocurrency—they are all seen to be overpriced. Analyzing these stocks’ financial fundamentals and market dynamics is necessary to understand why they are associated with downside risks. Fro